Atlas Trials

Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine

Clinical trial NCT04531072 · COMPLETED

Trial details

NCT number
NCT04531072
Sponsor
Fogarty International Center of the National Institute of Health
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Drug Interaction
Start date
2018-09-18
Primary completion
2019-05-15
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.